Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate 3.0 Tesla Magnetic Resonance Imaging of the Breasts in High Risk Women

NCT01409226 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01409226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01409226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate 3.0 Tesla Magnetic Resonance Imaging of the Breasts in High Risk Women
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2009
Completion date
January 31, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, breast cancer